Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
02/18/1993 | WO1993003134A1 Process for isolating and purifying recombinant interleukin-7 |
02/18/1993 | WO1993003062A1 Method of preferential labelling of a phycobiliprotein with a second dye to enable multiple color assay |
02/18/1993 | WO1993003061A1 Hematopoietic stem cell multiplier |
02/18/1993 | WO1993003060A1 Amide derivatives of antibiotic a 40926 |
02/18/1993 | WO1993003058A2 NON-DESENSITIZING ANALOGS OF GnRH AND OTHER BIOLOGICALLY ACTIVE LIGANDS |
02/18/1993 | WO1993003057A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p.falciparum, related products and their use in producing vaccine compositions |
02/18/1993 | WO1993003056A1 Lanthionine bridged peptides |
02/18/1993 | WO1993003050A1 Novel cyclophilins, associating proteins and uses |
02/18/1993 | WO1993003035A1 Anti-hiv drug |
02/18/1993 | WO1993002708A1 Novel reagent for tumour imaging and therapy |
02/18/1993 | WO1993002704A1 Mixture of peptide constituents having vaccinating properties against paludism particularly due to plasmodium falciparum |
02/18/1993 | WO1993002702A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
02/18/1993 | WO1993002698A1 Monoclonal antibodies to leukocyte adhesion molecule-1 |
02/18/1993 | WO1993002696A1 T-cell membrane protein for b cell ig class switching |
02/18/1993 | WO1993002694A1 Retinol-binding receptor and complex |
02/18/1993 | WO1993002693A2 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
02/18/1993 | WO1993002691A1 Steroid hormone drug delivery |
02/18/1993 | WO1993002690A1 Diagnosis and treatment of autoimmune diseases |
02/18/1993 | WO1993002654A2 A method of inducing hemoglobin synthesis in red blood cells and uses therefor |
02/18/1993 | WO1992014696A3 SUBSTITUTED α-AMINOALDEHYDES AND DERIVATIVES |
02/18/1993 | DE4127256A1 Chromatographic isolation of proteins from e.g. blood esp. cytochrome C sepn. - by contacting with buffered macroporous cellulose@ beads, rinsing away impurities and eluting adsorbed proteins with different buffer |
02/18/1993 | CA2115246A1 Lanthionine bridged peptides |
02/18/1993 | CA2115061A1 Method of isolation of dna |
02/18/1993 | CA2114950A1 Treatment of cell populations |
02/18/1993 | CA2114942A1 Novel cyclophilins, associating proteins and uses |
02/18/1993 | CA2114647A1 Diagnosis and treatment of autoimmune diseases |
02/18/1993 | CA2114409A1 Nucleotide sequences coding for ribosome inactivating proteins |
02/18/1993 | CA2114223A1 Polypeptides capable of in vivo induction of antibodies themselves capable of inhibiting the invasion of red blood corpuscles by merozoites of p. falciparum, related products and their use in producing vaccine compositions |
02/18/1993 | CA2114220A1 Immunoassay for the simultaneous detection of hiv-1, hiv-2, htlv-i and htlv-ii antibodies |
02/18/1993 | CA2114112A1 Transgenic protein production |
02/18/1993 | CA2114103A1 Device for detecting aqueous contaminants |
02/18/1993 | CA2113837A1 Anti-hiv agent |
02/18/1993 | CA2113551A1 Highly stable recombinant yeasts for the production of recombinant proteins |
02/18/1993 | CA2112566A1 Non-desensitizing analogs of gnrh and other biologically active ligands |
02/18/1993 | CA2111116A1 Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein |
02/18/1993 | CA2110505A1 Infectious bursal disease virus recombinant poxvirus vaccine |
02/18/1993 | CA2092542A1 Hemopoietic stem cell multiplier |
02/18/1993 | CA2083273A1 Use of endothelial-leukocyte adhesion molecule-1 and antibodies thereto in the treatment of asthma |
02/17/1993 | EP0527212A1 Analyte determination in biological fluids in the presence of interfering substances. |
02/17/1993 | EP0514488A4 Retinoid receptor compositions and methods |
02/17/1993 | EP0245479B1 Shortened phosphoglycerate kinase promoter |
02/17/1993 | CN1069068A Recombinant avipox virus, culture of cells infected by this virus and vaccines for poultry derived from this virus |
02/17/1993 | CA2075685A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity |
02/17/1993 | CA2075662A1 Chromophore containing compounds and their use in determining interleukin-1b convertase activity |
02/16/1993 | US5187268 Gene encoding an anti-complement protein from vaccinia |
02/16/1993 | US5187267 DNA sequence for genetic transcription and generation of transformed plants |
02/16/1993 | US5187263 Genetically engineered, platelet derived growth factor protein |
02/16/1993 | US5187262 Pure protein from clones DNA siimilar to that found in the latex of the Rubber Tree; binding of chitin; fungicides |
02/16/1993 | US5187261 Peptide sequence of first seven amino acids of lambda bacteriophage protein fused to human serum albumin |
02/16/1993 | US5187158 Brain-specific drug delivery |
02/16/1993 | US5187157 Peptide boronic acid inhibitors of trypsin-like proteases |
02/16/1993 | US5187155 For inhibiting activation of Factor X |
02/16/1993 | US5187153 Methods of treatment using Alzheimer's amyloid polypeptide derivatives |
02/16/1993 | US5187151 Use of binding protein with igf-i as an anabolic growth promoting agent |
02/16/1993 | US5187098 DNA encoding hybrid streptokinases with plasminogen fibrin binding domains |
02/16/1993 | US5187091 Bacillus thuringiensis cryiiic gene encoding toxic to coleopteran insects |
02/16/1993 | US5187090 For tumor diagnosis |
02/16/1993 | US5187089 Variants wherein there are nonpolar amino acid substitutions at the substrate binding site |
02/16/1993 | US5187087 Recominbant herpesvirus of turkeys and live vector vaccines derived thereof |
02/16/1993 | US5187086 Molecules with antibody combining sites that catalyze hydrolysis reactions through use of a charged hapten |
02/16/1993 | US5187080 For inducing immune response in chickens |
02/16/1993 | US5187079 Glucose-repressible gene for the regulated expression of proteins and expression vector therefor |
02/16/1993 | US5187077 Leukaemia inhibitory factor |
02/16/1993 | US5187076 DNA sequences encoding BMP-6 proteins |
02/16/1993 | US5187075 Cloning and expression of a variant gene of platelet factor 4 and compositions thereof to modulate immune responses |
02/16/1993 | US5187063 Combining a muscle sample with antibodies which specifically bind to glycoprotein component of dystrophin/glycoprotein complex, detecing extent of binding and comparing with extent of binding in nondystrophic muscle tissue samples |
02/16/1993 | US5187061 Transducing particles and methods for their production |
02/16/1993 | US5186934 Bacillus thuringiensis gene encoding a coleopteran-active toxin |
02/16/1993 | US5186933 Synthesis and immunogenicity of rotavirus genes using a baculovirus expression system |
02/16/1993 | US5186931 Composition and method for supporting bone marrow transplantation |
02/16/1993 | US5186513 Softshell |
02/16/1993 | CA2049275A1 Purification of sf hemoglobin |
02/15/1993 | CA2076064A1 Derivatives of human haemoglobin, method for preparing them, products derived therefrom and use of these derivatives and products |
02/14/1993 | WO1993004165A1 DNA SEQUENCE ENCODING BOVINE α-LACTALBUMIN AND METHODS OF USE |
02/11/1993 | DE4126484A1 Anti-sense-RNA expression vectors - contain hybrid promoter sequences and viral DNA sequences i.e. HIV, in anti-sense direction, useful in prodn. of HIV-resistant cells |
02/10/1993 | EP0527063A1 Production of protein of interest in the milk of transgenic mammal |
02/10/1993 | EP0527056A1 Novel reagent for tumour imaging and therapy |
02/10/1993 | EP0526953A1 Multichain polypeptides or proteins and processes for their production |
02/10/1993 | EP0526952A2 Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same |
02/10/1993 | EP0526905A2 Multimers of the soluble forms of TNF receptors, their preparation and pharmaceutical compositions containing them |
02/10/1993 | EP0526883A2 Chondromodulin-II protein |
02/10/1993 | EP0526544A1 Therapeutic uses of actin-binding compounds |
02/10/1993 | EP0526472A1 Household general-purpose adhesive on a polyurethane basis. |
02/10/1993 | EP0526452A1 Hybrid immunoglobulins |
02/10/1993 | EP0403524B1 Preparation of nitruro compounds usable as radio-pharmaceutical products |
02/10/1993 | EP0396563B1 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus |
02/10/1993 | EP0167548B1 Cloning of cdna and expression of murine-interleukin-3 |
02/10/1993 | CN1068744A Asialoglycoprotein-conjugated medicinal agent |
02/10/1993 | CA2075611A1 Non-a, non-b hepatitis virus genome, polynucleotides, polypeptides, antigen, antibody, and detection systems |
02/09/1993 | WO1993002697A1 Production of peptide amides |
02/09/1993 | US5185444 Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages |
02/09/1993 | US5185441 Polypeptides that bind to CD2, the receptor on the surface of T-cells |
02/09/1993 | US5185440 cDNA clone coding for Venezuelan equine encephalitis virus and attenuating mutations thereof |
02/09/1993 | US5185438 Genetic engineering |
02/09/1993 | US5185432 Monoclonal antibodies and antigen for human non-small cell lung carcinoma and other certain human carcinomas |
02/09/1993 | US5185431 Isolated, purified glyoprotein factor having antitumor activity |
02/09/1993 | US5185430 Protein isolated from surface of mammalian or fish cells |
02/09/1993 | US5185324 Enzyme-inhibiting amino acid derivatives, a process for the preparation thereof, agents containing these, and the use thereof |
02/09/1993 | US5185323 Administering to reduce number of circulating platelets in bloodstream of mammals |
02/09/1993 | US5185321 Adding lysozyme to Lactobeicillus, incubating, hydrolyzing peptidoglycans, centriguging, adding to whey or fermented milk |